Magazine article from our research archive:

Heparin Products the Target of Deliberate Adulteration, Says Baxter CEO

Baxter's heparin products appear to have been the target of a deliberate adulteration scheme, Baxter (Deerfield, IL) CEO Robert L. Parkinson said on April 29, 2008, in testimony before the US House of Representatives' Committee on Energy and Commerce, Subcommittee on Oversight and Investigations.

Parkinson described the heparin situation as "a global and industry-wide crisis, with a root cause that was so novel and so insidious as to avoid the quality systems of a multitude of companies and the oversight of the world's most sophisticated drug regulatory agencies."

Parkinson then outlined the steps Baxter is taking to avoid similar situations in the future, including convening a group of ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!